Page 5 - Arthurf Ryan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Valley National Advisers Inc. raised its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,394 shares of the biopharmaceutical company’s stock after purchasing an additional 24 shares during the quarter. Valley […]

Trifecta Capital Advisors LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3,625.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,533 shares of the biopharmaceutical company’s stock after purchasing an additional 2,465 shares during the […]

Hartford Investment Management Co. trimmed its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,219 shares of the biopharmaceutical company’s stock after selling 96 shares during the quarter. Hartford Investment Management […]

Columbia Trust Co 01012016 grew its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 12.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,265 shares of the biopharmaceutical company’s stock after purchasing an additional 142 shares during the quarter. Columbia […]

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-three brokerages that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and eighteen have issued a buy recommendation on the […]